By Kat Greene ( March 17, 2017, 5:00 PM EDT) -- The Ninth Circuit on Thursday sealed a win for Amgen Inc. in a proposed class action alleging the company pushed off-label uses of anemia drug Aranesp, finding the suit was time-barred in part because the widow anchoring the case had been tied to an earlier, similar suit....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.